2011
DOI: 10.1007/s00253-011-3758-5
|View full text |Cite
|
Sign up to set email alerts
|

CHO cells in biotechnology for production of recombinant proteins: current state and further potential

Abstract: Recombinant Chinese hamster ovary cells (rCHO) cells have been the most commonly used mammalian host for large-scale commercial production of therapeutic proteins. Recent advances in cell culture technology for rCHO cells have achieved significant improvement in protein production leading to titer of more than 10 g/L to meet the huge demand from market needs. This achievement is associated with progression in the establishment of high and stable producer and the optimization of culture process including media … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
475
0
6

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 632 publications
(510 citation statements)
references
References 127 publications
2
475
0
6
Order By: Relevance
“…Research in this direction has been conducted to efficiently optimize the medium's composition, for example, by means of approaches that are based on the monitoring of changes in the concentration of the medium components and byproducts in the culture,100 as well as genomics‐ and proteomics‐based approaches 101. Through such efforts, as well as host cell modifications,102 the per‐cell production yield has increased nearly 10‐fold from 1986 to 2004 103. The composition of the various culture media that are used in biopharmaceutical manufacturing today has not been disclosed for commercial reasons, but the composition of a previously reported serum‐free culture medium that is used for CHO cells is detailed in Table 4 for reference.…”
Section: History Of Cell Culture Mediamentioning
confidence: 99%
“…Research in this direction has been conducted to efficiently optimize the medium's composition, for example, by means of approaches that are based on the monitoring of changes in the concentration of the medium components and byproducts in the culture,100 as well as genomics‐ and proteomics‐based approaches 101. Through such efforts, as well as host cell modifications,102 the per‐cell production yield has increased nearly 10‐fold from 1986 to 2004 103. The composition of the various culture media that are used in biopharmaceutical manufacturing today has not been disclosed for commercial reasons, but the composition of a previously reported serum‐free culture medium that is used for CHO cells is detailed in Table 4 for reference.…”
Section: History Of Cell Culture Mediamentioning
confidence: 99%
“…To increase productivity, many cellular pathways including energy metabolism, cell cycle, apoptosis and protein secretion have been extensively studied (Chen et al 2001;Kim and Lee 2002;Watanabe et al 2002;Ifandi and Al-Rubeai 2005;Seth et al 2006;Jayapal et al 2007;Kim et al 2012). Increasing cell density by either reducing apoptosis (Meents et al 2002;Figueroa et al 2007) or altering cell metabolism (Chen et al 2001) can lead to increase in product titers.…”
Section: Introductionmentioning
confidence: 99%
“…Current transfection strategies in cell line development are based on the random integration of the gene of interest into the host genome with a varying number of gene-copies depending on gene amplification strategies (Kim et al 2012). The cell clones obtained from these methods are quite heterogeneous and need to be screened thoroughly.…”
Section: Introductionmentioning
confidence: 99%